Can Nebivolol Reverse Inappropriate Left Ventricular Mass in Hypertensive Patients?

Stopped early · Phase 4

Conditions studied: Hypertension

In brief

The purpose of this study is to evaluate if a drug called nebivolol can reverse inappropriate left ventricular mass (LVM) when compared to the standard of care drug metoprolol.

Key facts

Study ID
NCT01605370
Run by
Mayo Clinic
People needed
1
Starts
2012-06-01
Expected to finish
2013-03-01
Last updated by the study team
2014-05-19

Who can join

Age: 30 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.